Table 3 Logistic regression analysis for determining patient characteristics associated with cure rates during the 3–6-months follow-up

Treatment

FUS

0.490(0.182–1.313)

0.156

0.407(0.097–1.708)

0.219

LEEP

1

1

Age

0.995(0.907–1.093)

0.921

0.867(0.749–1.003)

0.055

Educational background

<University

1.067(0.384–2.961)

0.901

1.040(0.345–3.137)

0.944

≥University

1

1

Contraception

Condom

0.282(0.036–2.216)

0.229

0.293(0.036–2.415)

0.254

Others

0.382(0.038–3.850)

0.415

0.316(0.030–3.373)

0.340

None

1

1

Lifetime sexual partners

1–2

1.000(1.000−3.185)

1.000

0.746(0.210–2.654)

0.651

≥ 3

1

1

Parity

0

0.435(0.091–2.072)

0.296

0.301(0.043–2.125)

0.228

1

1.152(0.213–6.222)

0.870

1.196(0.203–7.051)

0.843

≥ 2

1

1

HPV status

HPV16/18 infection

2.089(0.219–19.885)

0.522

1.548(0.145–16.473)

0.717

Non-HPV16/18 infection

2.700(0.281–25.977)

0.390

2.312(0.210−25.434)

0.493

Negative^*

-

-

-

-

Unknown

1

1